132 289

Cited 0 times in

Risk factors for the acquisition of carbapenem-resistant Escherichia coli in a tertiary care hospital in South Korea : a matched case-control study

Other Titles
 한국의 3차 병원에서 시행한 carbapenem 내성 대장균 획득의 위험인자에 대한 환자 대조군 연구 
 Dept. of Internal Medicine (내과학교실) 
Issue Date
Dept. of Medicine/석사
Background: Carbapenem resistance among Gram-negative bacilli has become an emerging threat worldwide. The objective of this study was to identify risk factors for the acquisition of carbapenem-resistant Escherichia coli (CRE).Methods: We conducted a matched case-control study involving 57 cases with acquisition of CRE and 114 controls (1:2 matched) selected among patients with carbapenem-susceptible E. coli between January 2006 and December 2010 in a 2,000-bed tertiary care hospital in South Korea. The two groups were matched for the site and date of E. coli isolation.Results: In univariate analysis, previous use of carbapenem (p<0.001), fluoroquinolone (p=0.001), and glycopeptide (p<0.001), total number of previous antibiotic treatments (p=0.004), and length of hospital stay (p=0.047) were significantly associated with CRE acquisition. However, the year of isolation, attending healthcare workers, department or ward at the time of isolation, and the existence of CRE during the hospital stay were not associated with CRE acquisition. In multivariate analysis, previous use of carbapenem [odds ratio (OR) 4.56, 95% confidence interval (CI) 1.44-14.457, p=0.009] and previous use of fluoroquinolone (OR 2.81, 95% CI 1.137-6.991, p=0.0253) were independent risk factors for CRE acquisition.Conclusions: In this institute, antibiotic selective pressure seems to be more important for CRE acquisition than nosocomial transmission
Files in This Item:
T012717.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 2. Thesis
Yonsei Authors
Ahn, Jin Young(안진영) ORCID logo https://orcid.org/0000-0002-3740-2826
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.